Patients for Safer Nuclear Medicine is a coalition of patient advocacy organizations and corporate partners who are dedicated to ensuring the safety of nuclear medicine scans. These tests are conducted once a minute, every day, to diagnose and treat millions of people with cancer as well as people with heart disease and brain disorders.
Together, we are dedicated to the development of federal policies that support safe, transparent, and effective nuclear medicine care.
Our first order of business is to increase transparency for patients and accountability for hospitals and clinics. We are asking the U.S. Nuclear Regulatory Commission (NRC) – which oversees nuclear medicine safety – to close a 42-year-old loophole that prevents the reporting of extravasations.
Join us! We have the power to make nuclear scans safer and protect thousands of people. Email us to become a member of this important coalition.
Together, we are dedicated to the development of federal policies that support safe, transparent, and effective nuclear medicine care.
Our first order of business is to increase transparency for patients and accountability for hospitals and clinics. We are asking the U.S. Nuclear Regulatory Commission (NRC) – which oversees nuclear medicine safety – to close a 42-year-old loophole that prevents the reporting of extravasations.
Join us! We have the power to make nuclear scans safer and protect thousands of people. Email us to become a member of this important coalition.
Patient Advocacy Partners
|
|
|
|
Corporate Partners
|
|
|
|
|
Coalition Position Statements & Policy Recommendations
Letter to NRC CommissionersSummary: We are hopeful that the NRC will recognize the analysis of trained industry experts who are not conflicted in the matter at hand and do the right thing by removing the 1980 reporting exemption.
Letter to Health Physics SocietySummary: We are contacting you to raise concern about public comments submitted by your predecessor to the Nuclear Regulatory Commission in 2020 regarding petition PRM-35-22. We believe the statement from HPS does not reflect “excellence in the science and practice of radiation safety.”
|
Comment for 9/2/21 HearingSummary: We urge the Commission to reject the extravasation recommendations of the Advisory Committee on the Medical Uses of Isotopes (ACMUI), grant PRM-35-22 for rulemaking, and adopt “Option 2” of the NRC Staff Preliminary Evaluation on the reporting of radiopharmaceutical extravasations as medical events.
Letter to CORARSummary: We are encouraging CORAR (Council on Radionuclides and Radiopharmaceuticals) Trade Association, to educate SNMMI members on the negative effects of radiopharmaceutical extravasations and the need to report significant occurrences.
|
Response to 9/2/21 HearingSummary: We ask the Nuclear Regulatory Commission to adopt recommendations made in the petition in Docket: NRC-2020-0141. We believe that patients, their physicians, and the NRC should all be made aware of radiopharmaceutical extravasations that exceed the medical event reporting limit.
Letter to the OASSummary: We commend the Organization of Agreement States (OAS) and fully agree that the petition before the NRC should be immediately accepted. Requiring the reporting of extravasations is medically necessary and will encourage providers to take the steps to ensure nuclear medicine is as safe and effective as possible.
| ||||||||||||